Advertisement

Journal of NeuroVirology

, Volume 24, Issue 3, pp 332–332 | Cite as

Correction to: Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event

  • Joseph R. Berger
  • Vineeta Malik
  • Stuart Lacey
  • Paul Brunetta
  • Patricia B. Lehane
Correction

Correction to: Journal of NeuroVirology

 https://doi.org/10.1007/s13365-018-0615-7

The article “Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event,” written by Joseph R. Berger, Vineeta Malik, Stuart Lacey, Paul Brunetta, and Patricia B. Lehane, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 5 March 2018 without open access.

With the author(s)’ decision to opt for Open Choice, the copyright of the article changed on 6 April 2018 to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright information

© The Author(s) 2018

Authors and Affiliations

  • Joseph R. Berger
    • 1
  • Vineeta Malik
    • 2
  • Stuart Lacey
    • 3
  • Paul Brunetta
    • 4
  • Patricia B. Lehane
    • 3
  1. 1.Department of Neurology, Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.F. Hoffmann-La Roche, Ltd.BaselSwitzerland
  3. 3.Roche Products Ltd.Welwyn Garden CityUK
  4. 4.Genentech, IncSouth San FranciscoUSA

Personalised recommendations